Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Liver Neoplasms × perflutren × Clear all

Phase

Phase NA 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Ovarian Neoplasms 1 Melanoma 1 Liver Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Sorafenib 18 Bevacizumab 6 Oxaliplatin 5 Melphalan 5 Leucovorin 5 Irinotecan 5 Cyclophosphamide 5 pembrolizumab 4 fludarabine 4 Nivolumab 4 Fluorouracil 4 Sirolimus 3 Ipilimumab 3 Gemcitabine 3 Filgrastim 3 Carboplatin 3 Capecitabine 3 spartalizumab 2 pazopanib 2 lenvatinib 2 ixabepilone 2 fludarabine phosphate 2 durvalumab 2 atezolizumab 2 Thiotepa 2 Temozolomide 2 Sirtuins 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Radiosurgery 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00955097 2013-10-21

Definity®

University of Louisville

Phase 1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡